Hypertensive disorders of pregnancy · women with gestational diabetes mellitus
Metformin showed no clear difference in hypertensive disorders of pregnancy compared with glibenclamide ‐ maternal outcomes (moderate certainty).
1 finding from 1 review
Postnatal depression ‐ not measured · women with gestational diabetes mellitus
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Postnatal depression · women with gestational diabetes mellitus
Lifestyle interventions may leads to lower postnatal depression compared with control ‐ Maternal outcomes (low certainty).
1 finding from 1 review
Maternal respiratory depression (< 8 breaths/min) · women in labour with planned vaginal delivery
1 finding from 1 review
Maternal respiratory depression (< 9, < 8 breaths/min) · women in labour with planned vaginal delivery
Remifentanil (PCA) showed no clear difference in maternal respiratory depression (< 9, < 8 breaths/min) compared with epidural/CSE (low certainty).
1 finding from 1 review
Maternal respiratory depression (< 8 breaths/min) · women in labour with planned vaginal delivery
Remifentanil (PCA) may leads to lower maternal respiratory depression (< 8 breaths/min) compared with remifentanil (continuous IV) (low certainty).
1 finding from 1 review
Maternal respiratory depression (< 8 breaths/min) · women in labour with planned vaginal delivery
1 finding from 1 review
Maternal respiratory depression (< 8 breaths/min) · women in labour with planned vaginal delivery
1 finding from 1 review
Hypertensive disorders of pregnancy · women with gestational diabetes mellitus
Insulin probably leads to higher hypertensive disorders of pregnancy (not defined) compared with anti‐diabetic agent (moderate certainty).
1 finding from 1 review
Postnatal depression ‐ not measured · women with gestational diabetes mellitus
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Perinatal mortality · pregnant women
1 finding from 1 review
Stillbirth · pregnant women
Nutritional education showed no clear difference in stillbirth compared with no counselling or education during pregnancy (low certainty).
1 finding from 1 review
Neonatal mortality · pregnant women
Nutritional education showed no clear difference in neonatal death compared with no counselling or education during pregnancy (low certainty).
1 finding from 1 review
Small‐for‐gestational age · pregnant women
Nutritional education showed no clear difference in small‐for‐gestational age compared with no counselling or education during pregnancy (low certainty).
1 finding from 1 review
Birthweight (g) · pregnant women
1 finding from 1 review
Gestational weight gain · pregnant women
1 finding from 1 review
Nipple pain 5‐point verbal descriptor scale · breastfeeding women with sore nipples
2 findings from 1 review
Death (fetal, neonatal, or later (up to 2 years' corrected age))** · women at risk of preterm birth (< 34 weeks' gestation)
Magnesium sulphate showed no clear difference in death (fetal, neonatal, or later (up to 2 years' corrected age))** compared with placebo (outcomes (moderate certainty).
1 finding from 1 review
Death or cerebral palsy · women at risk of preterm birth (< 34 weeks' gestation)
Magnesium sulphate showed no clear difference in death or cerebral palsy (up to school age)** compared with placebo (outcomes (low certainty).
2 findings from 1 review
Major neurodevelopmental disability at childhood · women at risk of preterm birth (< 34 weeks' gestation)
It is very uncertain whether magnesium sulphate changes major neurodevelopmental disability (school age)** compared with placebo (outcomes (very low certainty).
1 finding from 1 review